Skip to search formSkip to main contentSkip to account menu

Prader-Willi Syndrome

Known as: Prader Labhart Willi Syndrome, Syndrome, Prader-Willi, Labhart Willi Prader Fanconi Syndrome 
An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the… 
National Institutes of Health

Related topics

Related topics

49 relations
0.25 ML Somatropin 6.4 MG/ML Prefilled Syringe [Genotropin]1.5 ML Somatropin 6.67 MG/ML Cartridge [Omnitrope]1.5 ML Somatropin 6.67 MG/ML Pen Injector [Norditropin]2 ML Somatropin 10 MG/ML Pen Injector [Nutropin]

Broader (2)

Congenital DisordersCongenital chromosomal disease

Narrower (1)

Prader-Willi habitus, osteopenia, and camptodactyly

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Glucose homeostasis in Prader‐Willi syndrome and potential implications of growth hormone therapy
Diabetes mellitus is becoming a more frequently recognized complication of Prader‐Willi syndrome. It has been reported that as… 
Highly Cited
1999
Highly Cited
1999
Behavior and personality characteristics of children and young adults with Prader-Willi syndrome: a controlled study.
OBJECTIVE To analyze (1) which behavior and personality characteristics in Prader-Willi syndrome (PWS) are primarily linked to… 
Highly Cited
1998
Highly Cited
1998
Prader-Willi syndrome and cycloid psychoses.
The psychiatric symptomatology of people with Prader-Willi syndrome (PWS) has mainly been described in case reports and some… 
Highly Cited
1996
Highly Cited
1996
Is excessive daytime sleepiness characteristic of Prader-Willi syndrome? The effects of weight change.
OBJECTIVES To assess nighttime and daytime sleep patterns in patients with Prader-Willi syndrome and to examine the effects of… 
Highly Cited
1993
Highly Cited
1993
A complete YAC contig of the Prader-Willi/Angelman chromosome region (15q11-q13) and refined localization of the SNRPN gene.
Highly Cited
1991
Highly Cited
1991
Pituitary Evaluation and Growth Hormone Treatment in Prader-Willi Syndrome
Short stature, obesity, hypogonadism and intellectual impairment are the main characteristics of children with Prader-Willi… 
Highly Cited
1990
Highly Cited
1990
Fenfluramine in Prader-Willi syndrome: a double blind, placebo controlled trial.
A double blind trial was conducted to determine the effect of fenfluramine on the weight and behaviour of patients with the… 
1984
1984
Deletion of chromosome 15 (q11-13) in a Prader-Labhart-Willi syndrome clinic population.
Deletion of the long arm of chromosome 15 has recently been reported in a number of patients with the Prader-Labhart-Willi… 
Highly Cited
1982
Highly Cited
1982
Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases.
High-resolution chromosome analysis and multiple banding techniques were performed on blood samples from 40 patients with Prader… 
Highly Cited
1980
Highly Cited
1980
Prader‐Willi syndrome and a bisatellited derivative of chromosome 15
A de novo bisatellited derivative of chromosome 15, inv dup (15) (pter→q11 or 12::p11 or q11 or 12 →pter), was identified by… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)